Support individuals who are substance users. — iCan Qualifications Limited End-Point Assessment Health & Social Care Revision
This element focuses on equipping learners with a comprehensive understanding of various substances, their pharmacological effects, and patterns of use, en
Topic Synopsis
This element focuses on equipping learners with a comprehensive understanding of various substances, their pharmacological effects, and patterns of use, enabling them to promote harm reduction and support individuals through immediate and long-term interventions. Learners will apply person-centred approaches to facilitate safe practices, manage post-use situations, and aid in reducing substance dependency, integrating ethical, legal, and health frameworks within Northern Ireland's care sector.
Key Concepts & Core Principles
- Person-centred care: Tailoring support to an individual's preferences, needs, and values, ensuring they are an active partner in their own care.
- Safeguarding: Protecting vulnerable adults and children from abuse, neglect, or harm, following Northern Ireland's adult safeguarding protocols and the Safeguarding Board for Northern Ireland.
- Duty of care: A legal obligation to act in the best interest of individuals, avoiding harm and ensuring their safety and well-being.
- Confidentiality and data protection: Adhering to the Data Protection Act 2018 and UK GDPR, sharing information only with consent or when required by law.
- Equality, diversity, and inclusion: Promoting equal opportunities and respecting differences in culture, religion, sexuality, and disability, as outlined in the Equality Act 2010.
Exam Tips & Revision Strategies
- In written case studies, systematically identify the substance(s) involved, their effects, and the stage of change the individual is in before selecting appropriate interventions, referencing models like the Transtheoretical Model.
- During role-play assessments, use open-ended questions and reflective listening to build rapport; examiners will assess your ability to employ motivational interviewing techniques rather than give direct advice.
- Always reference relevant legislation (e.g., Northern Ireland's drug policy, the Misuse of Drugs Act 1971, and the Health and Personal Social Services (Northern Ireland) Orders) and organisational policies on substance use support.
- When evidencing support for reducing substance use, include measurable indicators of progress (e.g., reduction in frequency, improved personal relationships) and contingency plans for setbacks to demonstrate comprehensive planning.
- Link theoretical knowledge to practice: explain how understanding different substances' effects informs risk management, for example, recognising signs of opioid overdose versus stimulant psychosis and responding appropriately.
Common Misconceptions & Mistakes to Avoid
- Assuming all individuals who use substances want to stop immediately; failing to adopt a harm reduction approach when abstinence is not the goal, thus alienating the person.
- Not differentiating between physical dependence, psychological addiction, and recreational use, leading to inappropriate or unsupportive interventions that do not address the full context.
- Overlooking co-occurring mental health issues (dual diagnosis) and not integrating mental health support into substance use care planning, which reduces effectiveness.
- Neglecting the legal and ethical responsibilities around confidentiality and duty of care, such as incorrectly sharing personal information with family or authorities without consent or necessary safeguarding grounds.
- Failing to recognise personal biases or stigmatising attitudes that can hinder engagement; not reflecting on own practice to ensure ethical, empathetic support.
Examiner Marking Points
- Award credit for demonstrating accurate knowledge of at least three categories of substances (e.g., stimulants, depressants, hallucinogens), including their street names, administration methods, and both short-term and long-term physiological and psychological effects.
- Evidence of conducting a comprehensive risk assessment that identifies potential harms (e.g., overdose, blood-borne viruses) and implements proportionate safety measures, such as providing clean needle kits or naloxone training.
- Assess ability to deliver non-judgmental, factual information on harm reduction strategies, including safer substance use, overdose prevention, and local support services, tailored to the individual's readiness to change.
- Observation of effective support during a post-use scenario, including monitoring vital signs, managing withdrawal symptoms, applying first aid if necessary, and documenting incidents accurately.
- Award credit for designing a person-centred support plan that includes realistic, measurable goals for reducing substance use, relapse prevention strategies, and appropriate referrals to multidisciplinary teams.